Association between somatostatin gene polymorphisms and sporadic Alzheimer's disease in Chinese population

Neuroscience Letters

Volumn 465, Issue 2, 2009, Pages 181-183

  Xue, Sufang ^a   Jia, Longfei ^a   Jia, Jianping ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Polymorphism; Somatostatin

Indexed keywords

APOLIPOPROTEIN E4; GENOMIC DNA; SOMATOSTATIN;

3' UNTRANSLATED REGION; ADULT; AGE; AGED; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ARTICLE; CHINESE; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PATHOGENESIS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

3' UNTRANSLATED REGIONS; AGE FACTORS; AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HETEROZYGOTE; HUMANS; INCIDENCE; MALE; ODDS RATIO; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; SEX FACTORS; SOMATOSTATIN;

EID: 70349459597     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.09.002     Document Type: Article

References (17)

1. Blacker D., and Tanzi R.E. The genetics of Alzheimer disease: current status and future prospects. Arch. Neurol. 55 (1998) 294-296
2. Caccamo A., Oddo S., Sugarman M.C., Akbari Y., and LaFerla F.M. Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders. Neurobiol. Aging 26 (2005) 645-654
3. Davies P., Katzman R., and Terry R.D. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa. Nature 288 (1980) 279-280
4. De Strooper B., and Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci. 113 Pt 11 (2000) 1857-1870
5. Hahs D.W., McCauley J.L., Crunk A.E., McFarland L.L., Gaskell P.C., Jiang L., Slifer S.H., Vance J.M., Scott W.K., Welsh-Bohmer K.A., Johnson S.R., Jackson C.E., Pericak-Vance M.A., and Haines J.L. A genome-wide linkage analysis of dementia in the Amish. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B (2006) 160-166
6. Hama E., and Saido T.C. Etiology of sporadic Alzheimer's disease: somatostatin, neprilysin, and amyloid beta peptide. Med. Hypotheses 65 (2005) 498-500
7. Hayashi M., Yamashita A., and Shimizu K. Somatostatin and brain-derived neurotrophic factor mRNA expression in the primate brain: decreased levels of mRNAs during aging. Brain Res. 749 (1997) 283-289
8. Hiltunen M., Mannermaa A., Thompson D., Easton D., Pirskanen M., Helisalmi S., Koivisto A.M., Lehtovirta M., Ryynanen M., and Soininen H. Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland. Neurology 57 (2001) 1663-1668
9. Iwata N., Higuchi M., and Saido T.C. Metabolism of amyloid-beta peptide and Alzheimer's disease. Pharmacol. Ther. 108 (2005) 129-148
10. Iwata N., Tsubuki S., Takaki Y., Watanabe K., Sekiguchi M., Hosoki E., Kawashima-Morishima M., Lee H.J., Hama E., Sekine-Aizawa Y., and Saido T.C. Identification of the major Abeta1-42-degrading catabolic pathway in brain parenchyma: suppression leads to biochemical and pathological deposition. Nat. Med. 6 (2000) 143-150
11. Lee J.H., Cheng R., Santana V., Williamson J., Lantigua R., Medrano M., Arriaga A., Stern Y., Tycko B., Rogaeva E., Wakutani Y., Kawarai T., St. George-Hyslop P., and Mayeux R. Expanded genomewide scan implicates a novel locus at 3q28 among Caribbean hispanics with familial Alzheimer disease. Arch. Neurol. 63 (2006) 1591-1598
12. Ling Y., Morgan K., and Kalsheker N. Amyloid precursor protein (APP) and the biology of proteolytic processing: relevance to Alzheimer's disease. Int. J. Biochem. Cell Biol. 35 (2003) 1505-1535
13. Lu T., Pan Y., Kao S.Y., Li C., Kohane I., Chan J., and Yankner B.A. Gene regulation and DNA damage in the ageing human brain. Nature 429 (2004) 883-891
14. Saido T.C., and Iwata N. Metabolism of amyloid beta peptide and pathogenesis of Alzheimer's disease. Towards presymptomatic diagnosis, prevention and therapy. Neurosci. Res. 54 (2006) 235-253
15. Saito T., Iwata N., Tsubuki S., Takaki Y., Takano J., Huang S.M., Suemoto T., Higuchi M., and Saido T.C. Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation. Nat. Med. 11 (2005) 434-439
16. Selkoe D.J. Clearing the brain's amyloid cobwebs. Neuron 32 (2001) 177-180
17. Vepsalainen S., Helisalmi S., Koivisto A.M., Tapaninen T., Hiltunen M., and Soininen H. Somatostatin genetic variants modify the risk for Alzheimer's disease among Finnish patients. J. Neurol. 254 (2007) 1504-1508